• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Verrica Announces Positive Topline Results From Phase 2 Study Of VP-315 For BCC

    GLOBENEWSWIRE

    Verrica Announces that YCANTH Receives New Chemical Entity Status

    GLOBENEWSWIRE

    Verrica Pharma to Host Virtual KOL Event Discussing the Approval of YCANTH

    GLOBENEWSWIRE

    FDA approves Verrica`s skin infection treatment, enters into non-binding term sheet for $125M loan

    ENDPTS

    Verrica`s drug gets US nod as first treatment for a type of skin infection

    REUTERS

    JAMA Dermatology Publishes Results from Verrica’s Pivotal Phase III CAMP Trials

    GLOBENEWSWIRE

    Verrica Pharmaceuticals Provides Regulatory Update on VP-102

    GLOBENEWSWIRE

    Verrica`s Announces Presentation of Positive Data from Clinical Trials of VP-102

    BIOSPACE

    Verrica Pharma`s Announces Presentation of Positive Data from Trials of VP-102

    BIOSPACE

    JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection

    EDQM

    India`s oldest pharma company Bengal Chemicals turns profitable after 64 years

    ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.